New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers
ST. LOUIS and DURHAM, N.C., Jan. 27 /PRNewswire-FirstCall/ -- As farmers
look to get more out of each acre of farmland, St. Louis-based Monsanto
(NYSE: MON ) is exploring unique ways to discover and deliver more desirable
traits through the seed. Monsanto's new collaboration with GrassRoots
Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants
HACKENSACK, N.J., July 16 /PRNewswire/ --- Over the past two decades,
stem cell transplantation has evolved from being an experimental treatment
to one that is a viable option for patients with hematologic (blood)
malignancies and other life-threatening blood disorders. Researchers and
Wisconsin Economic Summit Aims for a New Lease on Life
MADISON Has the Wisconsin Economic Summit run its course? With Summit IV just a few weeks away, thats a question that skeptics and supporters alike will ask about the University of Wisconsin Systems two-day short course on the states economy.
The best answer, to be fair, is wait-and-see. If the...
Lucigen aims to fill holes in genetic maps with new technique
Middleton, Wis. -- Lucigen Corporation , which provides molecular cloning products to genetics researchers, has been awarded a patent on a new way to clone genes that may solve a persistent problem in genetics.
Researchers often find missing pieces or gaps when they analyze genes using standa...
Fusion 2005 symposium aims to bring CIOs to the boardroom
Madison, Wis. CIOs and other information-technology movers will get a crash course in getting their foot in the boardroom door at the Fusion 2005 CEO-CIO Symposium on March 2 in the Fluno Center.
The event, presented by the Wisconsin IT Directors Council and produced in conjunction with W...
New biomedical institute aims to unite business and academia in SE Wisconsin
Doyle announces a new biomedical institute on Monday in Milwaukee. Milwaukee Increased collaboration between academic researchers and companies in southeastern Wisconsin is the goal behind the formation of a biomedical research institute that is being established with a $1 million grant from...
Wisconsin aims to keep up in changing stem-cell world
Madison, Wis. Recent developments in Washington and Korea could have a lasting impact on Wisconsin's stem cell community, putting more roadblocks in scientists' search for funding.
Following a successful effort by South Korean scientists to create "patient-specific" embryonic-stem-cell lines ...
Wisconsin consortium aims for defense business
Congress has approved a $500,000 start-up grant for the recently announced Wisconsin Security Research Consortium, a non-profit group for classified, defense-related projects.
The consortium, led by the Wisconsin Technology Council, will also initially include the UW System, the Medical College...
Webaroo aims to make mobile search relevant
The so-called mobile Internet is neither conveniently mobile, nor completely the Internet. Mobile devices hardly have the display or storage to support a rich Web experience, and mobile networks are not ubiquitous, high-bandwidth or cheap enough to support an always-connected browsing experience....
Securitas aims to counter virus behavior
Madison, Wis. - Profit-driven hackers, armed with increasingly sophisticated malicious software, have caused over $8 billion in damage to corporation computer systems this year alone, and variations of existing viruses are proliferating faster than ever before. Fortunately for beleagured business...
RFID pilot project aims to improve blood banks
Madison, Wis. - To find out whether radio frequency identification can improve the speed and accuracy of the blood banking process, the RFID Lab at the University of Wisconsin-Madison is partnering with three blood banks and multiple vendor partners on what is being called an "end-to-end" r...
Research consortium aims to bring security and defense contracts to Wisconsin
Madison, Wis. - Wisconsin ranks in the lower half of states in federal contracting dollars, but a new consortium is ready to help researchers and companies land more federal security contracts.
The Wisconsin Security Research Consortium , funded by a grant from the U.S. Small Business Admini...
Microparts interest group workshop
...development of novel
contact, optical and XCT probing techniques, machine
calibration, stability, traceability and calibration
artefacts. The workshop aims
to disseminate the
work of the project to the wider audience and discuss
related research and development topics.
Updates on the d...
SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS
...arch, development, commercialization and license agreement for novel flavor ingredients intended to provide a cooling taste effect. The collaboration aims
to identify novel cooling flavors that do not have the limitations of currently available agents. Senomyx and Firmenich signed a second agreement in N...
Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies
...nt providers, oil companies and lubricant additive manufacturers. By bringing together interested parties from each of these industry sectors, Ricardo aims
to create a framework in which fundamental challenges in this area can be investigated and researched in a pre-competitive manner for the mutual benef...
Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
...eople living with RA.
New Way RA provides new, practical information in an accessible, online format for adults living with RA. The show also aims
to raise awareness about RA, a chronic, inflammatory and potentially disabling condition that affects more than one million Americans, 70 percent of w...
Sanofi-aventis Announces Second Quarter 2009 Results
...icularly good progress in the year to date, across each of the three key themes:
Increasing innovation in R&D - Our new R&D approach aims
to foster greater creativity and innovation, while remaining focused on patient needs. Streamlined organizational structures will make our R&D mor...
St. John's Hospital Acquires Latest Technology in Robotic-Assisted Surgery
...ity to maneuver instruments during a minimally invasive procedure.
With the acquisition in late June of the dual console da Vinci, St. John's aims
to be the Midwest leader in training for robotic surgery. The acquisition of the new dual-console da Vinci SI Surgical System will allow greater colla...
DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies
...iverse RNA-based structures with near-crystal structure accuracy. With this NIH project, DNA Software is modeling ribosome structure and function and aims
to predict the 3D structures of complete ribosomes of clinically relevant pathogens.
Novel Software for Modeling PCR Reaction Rates and Diagnostic...
4th BTLtec Conference on 24-25 Sep in Graz, Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies, Syngas Application, BTL Value Chain and a Site Visit to the Biomass CHP Gussing Plant.
...BTL industry consortium, the OPTFUEL project. Established in February 2009, The OPTFUEL consortium is made up of 10 partners from 5 countries. OPTFUEL aims
to demonstrate the production chain of synthetic fuels from biomass (BTL) and the potential of pollutants emissions reduction in vehicle applications....
Politicians to Drive on Straw-Based Bioethanol at the Climate Change Conference
...nsportation fuel or heating oil for private home and commercial property.
Facts about Partnership for Biofuels
Partnership for Biofuels aims
to develop the framework conditions for Danish technology in order to produce 2nd generation biofuels. The partnership consists of Novozymes A/S, Inbi...
Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
...ompounds. The company believes that its library of marine microbes will be the next source of drug discovery for the pharmaceutical industry. Magellan aims
to develop and optimize drug candidates to treat cancer, infectious diseases, and inflammation. For additional information, please refer to the compan...
Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
...sting agreement to test drug development candidates for their potential to cause cardiotoxicity, or damage to heart tissue. The two-year collaboration aims
to enhance drug safety testing in order to bring promising therapies to patients faster.
Under this agreement, CDI will supply purified cardiomy...
New Probiotics Bacteria Supplier ProbioFerm, LLC Provides the Highest Quality Beneficial Bacteria Available for Product Development
...ods. Other important certifications like Certificates of Analysis are readily provided with their in-house Quality Assurance testing lab. This company aims
to deliver all your Probiotic needs from start to finish, ensuring clients receive the highest quality product there is.
For additional informatio...
Does Synthetic Biology Need Synthesized Ethics?
According to the U.K. Royal Academy of Engineering, synthetic biology aims
to design and engineer biologically based parts, novel devices and systems ...lars supported by a grant from the Alfred P. Sloan Foundation. The Project aims
to foster informed public and policy discourse concerning the advancement o...
AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS
...ieder AG said: "We are very proud of this award.
Good investment tends to not only promote advances in technology, but also to
promote individuals and aims
that are as visionary as they are clear. Our MIG
fund managers also pay particular attention to ensuring that the target
markets of our potential inve...
Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
...elation to blending targets and supply, achieved in each country," said Balasingam.
She continues, "A growing trend is seen as most SEA countries aims
to increase the blend requirement for bio-diesel. Focus into local markets and meeting National Bio-fuel Policy requirements will be the future outloo...
'Designer molecules' being developed to fight disease
...tive medicine and tissue engineering.
The research carried out by Shikha Sharma in Dr Nick Brindle's group in Department of Cardiovascular Sciences aims
to allow researchers to rapidly make 'designer proteins' that can bind to disease causing molecules in the body.
Shikha Sharma said "There are mil...
Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
...rate spin-offs resulting from successful early stage technology research. By providing corporate development support as well as funding, Allied Minds aims
to guide early stage companies to commercial success, thereby generating value for all stakeholders. For more information, logon to www.alliedminds...
Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 'CONNECTION' Trial of Dimebon in Patients With Alzheimer's Disease
...any focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims
to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a...
Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
...ry organ printing technology to solve critical problems in transplant medicine, cardiovascular medicine, tissue repair, and medical research. Organovo aims
to solve complex medical problems with one overarching goal: to benefit the health and lives of patients. www.organovo.com
Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark
... Technology, Aalborg University. Close
collaborations with academia are essential for Santaris Pharma's expanding
microRNA therapeutics program, which aims
at translating the basic knowledge
about microRNAs in disease into development of novel medicines with the
potential to improve human health. I am loo...
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on GenSpera, Inc.
...resence of prostate cancer. The Company is also working to identify additional candidates in this program.
Based in San Antonio, Texas, GenSpera aims
to begin trading on the Over-the-Counter Bulletin Board (OTC.BB) in the third quarter 2009.
About Crystal Research Associates, LLC
Phosphagenics Announces Completion of Transdermal Patch Prototypes
...er orally or intravenously. It is more potent than morphine with fewer side effects. Worldwide sales of oxycodone exceed $US1.5 billion. Phosphagenics aims
to become the first company to provide chronic pain sufferers with a sustained-release transdermal system that delivers oxycodone into the bloodstream...
Roche Announces Back-to-Basics Approach to Diabetes Care - Simpler is Better
...e world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims
at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.
In 2008, R...
Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
...nd improving the quality of life for all people through the use of biotechnology. Through strategic alliances with other industry leaders, the Company aims
to extend its reach around the world. More information is available at http://www.takara-bio.com .
Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management
...f Merck Serono to no longer
invest in diabetes research and development. It aims
to advance promising
assets for cardio-metabolic diseases (with a primary f...nt unmet needs remain.
Poxel is a new RIPCO that aims
to advance promising assets for
cardio-metabolic diseases from Research to ...
AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
...isease by as little as 30 % - and that's only if the patient takes the
necessary medication correctly and regularly. In contrast, our vaccine
at decreasing the cholesterol transfer from HDL to LDL, thus
increasing the concentration of the beneficial HDL. This vaccine approach
with its long-l...
Synthetic Biology on the Rise
According to the U.K. Royal Academy of Engineering, synthetic biology aims
to design and engineer biologically based parts, novel devices and systems ...olars supported by a grant from the Alfred P. Sloan Foundation. The Project aims
to foster informed public and policy discourse concerning the advancement o...
Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology
...very smooth for us and for our patients. It enabled us to verify the position of the tumor prior to each treatment and deliver the dose in a way that aims
to avoid other tissues already weakened by the patient's chronic pulmonary disease. The Novalis Tx is an exceptional machine for treating tumors and m...